Yüklüyor......
Changing strategies for target therapy in gastric cancer
In spite of a worldwide decrease in the incidence of gastric cancer, this malignancy still remains one of the leading causes of cancer mortality. Great efforts have been made to improve treatment outcomes in patients with metastatic gastric cancer, and the introduction of trastuzumab has greatly imp...
Kaydedildi:
| Yayımlandı: | World J Gastroenterol |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Baishideng Publishing Group Inc
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4716029/ https://ncbi.nlm.nih.gov/pubmed/26811656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i3.1179 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|